Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Investigation of the Effectiveness of Upper Limb Exercise in COPD Patients
The aim of the study is to investigate the efficacy of upper limb exercise training in
Chronic Obstructive Pulmonary Disease (COPD) patients. For the purpose of the study, a
controlled trial will be conducted within Respiratory Clinic of Nicosia General Hospital. The
sample will be divided in two groups. The intervention group will participate in a pulmonary
rehabilitation program which includes upper and lower extremities exercises, with addition of
arm ergometer. The second group (control group) will participate in the same program but
without arm ergometer training.
The study's hypothesis is that the intervention group will improve the outcome measures
significantly better than the control group.
Status | Recruiting |
Enrollment | 44 |
Est. completion date | May 31, 2020 |
Est. primary completion date | May 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosis of COPD confirmed by clinical examination and a pulmonary function test - Stable clinical condition (without recent respiratory system infections or any exacerbation of the disease) - Patients must be willing to re evaluate at the end of the study - Patients must be willing to give written consent for their participation in the study Exclusion Criteria: - Age < 18 years old - Unstable cardiac disease - Musculoskeletal and neurological diseases that could affect exercise performance or preclude exercise - Patients of COPD final stage or other serious disease final stage - Significant cognitive or psychiatric impairment that would lead to an inability to follow simple commands in a group setting |
Country | Name | City | State |
---|---|---|---|
Cyprus | Respiratory Clinic, Nicosia General Hospital | Nicosia |
Lead Sponsor | Collaborator |
---|---|
European University Cyprus | Nicosia General Hospital |
Cyprus,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Upper Limb Muscle Strength, biceps brachii | Assess biceps brachii via hand-held dynamometer Micro FET2 | Before Intervention | |
Primary | Upper Limb Muscle Strength, biceps brachii | Assess biceps brachii via hand-held dynamometer Micro FET2 | At 3 months (at the end of intervention) | |
Primary | Upper Limb Muscle Strength, biceps brachii | Assess biceps brachii via hand-held dynamometer Micro FET2 | Change from Baseline Biceps Brachii Muscle Strength at 3 months | |
Primary | Upper Limb Muscle Strength, triceps | Assess triceps via hand-held dynamometer Micro FET2 | Before Intervention | |
Primary | Upper Limb Muscle Strength, triceps | Assess triceps via hand-held dynamometer Micro FET2 | At 3 months (at the end of intervention) | |
Primary | Upper Limb Muscle Strength, triceps | Assess triceps via hand-held dynamometer Micro FET2 | Change from Baseline Triceps Muscle Strength at 3 months | |
Primary | Upper Limb Muscle Strength, hand-grip | Assess via jamar hand dynamometer | Before Intervention | |
Primary | Upper Limb Muscle Strength, hand-grip | Assess via jamar hand dynamometer | At 3 months (at the end of intervention) | |
Primary | Upper Limb Muscle Strength, hand-grip | Assess via jamar hand dynamometer | Change from Baseline Handgrip Muscle Strength at 3 months | |
Primary | Dyspnea, modified Borg Scale | Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea | Before Intervention | |
Primary | Dyspnea, modified Borg Scale | Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea | At 3 months (at the end of intervention) | |
Primary | Dyspnea, modified Borg Scale | Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea | Change from Baseline Dyspnea at 3 months | |
Primary | Dyspnea, mMRC Scale | Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing | Before Intervention | |
Primary | Dyspnea, mMRC Scale | Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing | At 3 months (at the end of intervention) | |
Primary | Dyspnea, mMRC Scale | Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing | Change from Baseline Dyspnea at 3 months | |
Primary | Fatigue | Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue | Before Intervention | |
Primary | Fatigue | Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue | At 3 months (at the end of intervention) | |
Primary | Fatigue | Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue | Change from Baseline Fatigue at 3 months | |
Primary | Health-related Quality of Life, SGRQ | Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health | Before Intervention | |
Primary | Health-related Quality of Life, SGRQ | Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health | At 3 months (at the end of intervention) | |
Primary | Health-related Quality of Life, SGRQ | Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health | Change from Baseline at 3 months | |
Primary | Health-related Quality of Life, CAT | Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. | Before Intervention | |
Primary | Health-related Quality of Life, CAT | Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. | At 3 months (at the end of intervention) | |
Primary | Health-related Quality of Life, CAT | Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. | Change from Baseline at 3 months | |
Primary | Activities of Daily Living with Upper Limbs | Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level | Before Intervention | |
Primary | Activities of Daily Living with Upper Limbs | Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level | At 3 months (at the end of intervention) | |
Primary | Activities of Daily Living with Upper Limbs | Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level | Change from Baseline time at 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|